MarketPeel
Insider Trading Intelligence
RL

R01 Capital Llc

NBY
10% OWNER · NOVABAY PHARMACEUTICALS, INC. · CIK 0002091715
FILING MIX · LIFETIME90%/10%
BUYS
9
SELLS
1
TOTAL VALUE
$45.68M
COMPANIES
1
ACTIVE SINCE
Oct 2025
HOLDINGS NOW
0
AVG SELL PX
$1.09
TRADE KIND
SHOWING 10 / 10
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for R01 Capital Llc. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
NBY · 0 shares · as of Jun 15, 2026
014,201,52028,403,04042,604,56056,806,0802026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2025
2026
2026
FLOW · 9 buys / 1 sellsCOVERAGE · 3 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
11,332,0200Jun 15, 2026Jun 17, 2026View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
11,332,020$0.00$27.2K22,693,236Jun 15, 2026Jun 17, 2026View →
NBY
NOVABAY PHARMACEUTICALS, INC.
SALE
24,720$1.09$26.9K22,668,516Jun 15, 2026Jun 17, 2026View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
53,679,974$0.85$45.63M53,679,974Jan 16, 2026May 19, 2026View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
56,806,08056,806,080Oct 21, 2025Nov 3, 2025View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
11,361,21611,361,216Oct 21, 2025Apr 30, 2026View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
134,375134,375Oct 16, 2025Oct 20, 2025View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
220,663220,663Oct 16, 2025Oct 20, 2025View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
2,702,7032,702,703Oct 16, 2025Nov 3, 2025View →
NBY
NOVABAY PHARMACEUTICALS, INC.
PURCHASE
11,332,02011,332,020Oct 16, 2025Apr 30, 2026View →
Other insiders · NBY
Loading peer insiders…
About this filer
CIK 0002091715
ROLE
10% Owner
PRIMARY
NBY
COMPANIES
1
ACTIVE SINCE
Oct 2025
MARKETPEEL · /INSIDER/0002091715DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback